Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Summary
This is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with locally advanced or metastatic solid tumors for whom alternative therapies do not exist or available therapies are intolerable or no longer effective.
Official title: A Dose-Escalation and Expansion Study of XB010 as a Single Agent and Combination Therapy in Subjects With Locally Advanced or Metastatic Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
396
Start Date
2024-08-06
Completion Date
2027-10-20
Last Updated
2026-06-22
Healthy Volunteers
No
Conditions
Interventions
XB010
IV administration of XB010
Pembrolizumab
IV administration of Pembrolizumab
Locations (20)
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California, United States
UCLA Department of Medicine - Hematology/Oncology
Los Angeles, California, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, Florida, United States
Winship Cancer Institute
Atlanta, Georgia, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Siteman Cancer Center
St Louis, Missouri, United States
Montefiore Medical Center - Montefiore Medical Park
The Bronx, New York, United States
Carolina BioOncology Institute
Huntersville, North Carolina, United States
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
SCRI Oncology Partners
Nashville, Tennessee, United States
NEXT Austin
Austin, Texas, United States
Baylor University Medical Center
Dallas, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Inova Schar Cancer
Fairfax, Virginia, United States
NEXT Virginia
Fairfax, Virginia, United States
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
Sarah Cannon Research Institute London
London, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom